Cerebral oxidative stress induces spatial working memory dysfunction in uremic mice: Neuroprotective effect of tempol

Nephrology Dialysis Transplantation

Volumn 29, Issue 3, 2014, Pages 529-538

  Fujisaki, Kiichiro ^a   Tsuruya, Kazuhiko ^a   Yamato, Mayumi ^b   Toyonaga, Jiro ^a   Noguchi, Hideko ^a   Nakano, Toshiaki ^a   Taniguchi, Masatomo ^a   Tokumoto, Masanori ^c   Hirakata, Hideki ^d   Kitazono, Takanari ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c FUKUOKA DENTAL COLLEGE   (Japan)

^d FUKUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Chronic kidney disease; Cognitive dysfunction; Oxidative stress; Uremia

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; TEMPOL; 8-OXO-7-HYDRODEOXYGUANOSINE; AMINE OXIDE; ANTIOXIDANT; DEOXYGUANOSINE; NEUROPROTECTIVE AGENT; SPIN LABELING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CELL; C57BL 6 MOUSE; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DNA DAMAGE; ELECTROCOAGULATION; HIPPOCAMPAL CA3 REGION; KIDNEY CORTEX; MALE; MOUSE; NEPHRECTOMY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIAL ARM MAZE TEST; SPATIAL MEMORY; UREMIA; WORKING MEMORY; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHRONIC KIDNEY FAILURE; COGNITION DISORDERS; COMPLICATION; DRUG EFFECTS; DRUG SCREENING; HIPPOCAMPUS; MAZE TEST; MEMORY DISORDERS; METABOLISM; SHORT TERM MEMORY; SPIN LABELING;

ANIMALS; ANTIOXIDANTS; COGNITION DISORDERS; CYCLIC N-OXIDES; DEOXYGUANOSINE; DRUG EVALUATION, PRECLINICAL; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RENAL INSUFFICIENCY, CHRONIC; SPATIAL MEMORY; SPIN LABELS; UREMIA;

EID: 84895762758     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft327     Document Type: Article

References (34)

1. Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004; 107: 1-16
2. Hailpern SM, Melamed ML, Cohen HW et al. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2007; 18: 2205-2213
3. Kurella M, Chertow GM, Fried LF et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 2005; 16: 2127-2133
4. Murray AM, Tupper DE, Knopman DS et al. Cognitive impairment in hemodialysis patients is common. Neurology 2006; 67: 216-223
5. Seliger SL, Siscovick DS, Stehman-Breen CO et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol 2004; 15: 1904-1911
6. Sehgal AR, Grey SF, DeOreo PB et al. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis 1997; 30: 41-49
7. Khatri M, Nickolas T, Moon YP et al. CKD associates with cognitive decline. J Am Soc Nephrol 2009; 20: 2427-2432
8. Row BW, Kheirandish L, Neville JJ et al. Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia. Pediatr Res 2002; 52: 449-453
9. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000; 72: 621S-629S
10. Wolf H, Grunwald M, Kruggel F et al. Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging 2001; 22: 177-186
11. Deng G, Vaziri ND, Jabbari B et al. Increased tyrosine nitration of the brain in chronic renal insufficiency: reversal by antioxidant therapy and angiotensin-converting enzyme inhibition. J Am Soc Nephrol 2001; 12: 1892-1899
12. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473
13. Gagnon RF, Duguid WP. A reproducible model for chronic renal failure in the mouse. Urol Res 2008; 11: 11-14
14. Boffa JJ, Arendshorst WJ. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. J Am Soc Nephrol 2005; 16: 117-124
15. Nishiyama A, Yao L, Nagai Y et al. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 2004; 43: 841-848
16. Arendash GW, King DL, Gordon MN et al. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 2001; 891: 42-53
17. Morgan D, Diamond DM, Gottschall PE et al. A β peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000; 408: 982-985
18. Gonzalez-Aguilar F, De Robertis E. A formalin-perfusion method for histophysiological study of the central nervous system with the electron microscopy. Neurology 1963; 13: 758-763
19. Liu M, Liang Y, Chigurupati S et al. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol 2008; 19: 1360-1370
20. Tsuruya K, Ninomiya T, Tokumoto M et al. Direct involvement of the receptor- mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 2003; 63: 72-82
21. Qu B, Boyer PJ, Johnston SA et al. Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice. J Neurol Sci 2006; 244: 151-158
22. De Deyn PP, D'Hooge R, Van Bogaert PP et al. Endogenous guanidino compounds as uremic neurotoxins. Kidney Int Suppl 2001; 78: S77-S83
23. Ye S, Nosrati S, Campese VM. Nitric oxide modulates the neurogenic control of blood pressure in rats with chronic renal failure. J Clin Invest 1997; 99: 540-548
24. Aoyagi K, Akiyama K, Shahrzad S et al. Formation of guanidinosuccinic acid, a stable nitric oxide mimic, from argininosuccinic acid and nitric oxide-derived free radicals. Free Radic Res 1999; 31: 59-65
25. Chen G, Chen KS, Knox J et al. Morris, R. G. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000; 408: 975-979
26. Arakawa H. Age dependent effects of space limitation and social tension on open-field behavior in male rats. Physiol Behav 2005; 84: 429-436
27. Li M, Bertout JA, Ratcliffe SJ et al. Acute anemia elicits cognitive dysfunction and evidence of cerebral cellular hypoxia in older rats with systemic hypertension. Anesthesiology 2010; 113: 845-858
28. Palumbo ML, Fosser NS, Rios H et al. Loss of hippocampal neuronal nitric oxide synthase contributes to the stress-related deficit in learning and memory. J Neurochem 2007; 102: 261-274
29. Kuhad A, Chopra K. Effect of sesamol on diabetes-associated cognitive decline in rats. Exp Brain Res 2008; 185: 411-420
30. Liang Q, Smith AD, Pan S et al. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease. Biochem Pharmacol 2005; 70: 1371-1381
31. Daumas S, Halley H, Francés B et al. Encoding, consolidation, and retrieval of contextual memory: differential involvement of dorsal CA3 and CA1 hippocampal subregions. Learn Mem 2005; 12: 375-382
32. Deng-Bryant Y, Singh IN, Carrico KM et al. Neuroprotective effects of tempol, a catalytic scavenger of peroxynitrite-derived free radicals, in a mouse traumatic brain injury model. J Cereb Blood FlowMetab 2008; 28: 1114-1126
33. Kielstein JT, Zoccali C. Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 2008; 17: 609-615
34. de la Torre JC, Aliev G. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. J Cereb Blood Flow Metab 2005; 25: 663-672